MEDIA NEWSROOM
The content on this page was provided to help in your search for information about PCNA, cardiovascular nursing, and cardiovascular disease.
Latest Press Releases
-
in Association News
PCNA awards Boston advertising agency $5,000 to fund employee wellness programs after winning national challenge
PCNA awards Boston advertising agency $5,000 to fund employee wellness programs after winning national challenge First Annual PCNA Prevention Challenge impacts corporate wellness, aids in spreading awareness about employee health programs BOSTON - The Preventive Cardiovascular Nurses Association (PCNA) has selected Boston-based advertising agency, Allen & Gerritsen, as the winner… -
in Scientific Conferences
MEDIA ALERT: PCNA 19th Annual Symposium to Feature CVD Prevention Science, Education
MEDIA ALERT: PCNA 19th Annual Symposium to Feature CVD Prevention Science, Education LAS VEGAS, May 2, 2013 Preventive Cardiovascular Nurses Association (PCNA) will be hosting their 19th Annual Symposium from May 2-4, 2013 at the Paris Las Vegas Hotel in Las Vegas, Nevada. The scientific symposium will feature keynote speakers… -
in Scientific Conferences
PCNA Response: TERISA Trial, ACC.13 Scientific Sessions
SAN FRANCISCO, March 10, 2013 The TERISA Trial, presented on Sunday at the American College of Cardiology Scientific Sessions 2013, revealed data that shows the effectiveness of renolazine in reducing angina frequency and SL NTG in patients with type 2 diabetes, CAD and chronic angina. “This promising data shows beneficial… -
in Scientific Conferences
PCNA Response: TACT Trial, ACC.13 Scientific Sessions
SAN FRANCISCO, March 10, 2013 The Trial to Assess Chelation Therapy (TACT), presented on Sunday at the American College of Cardiology 2013 Scientific Sessions, revealed results of partnering high-dose vitamins with chelation therapy for a primary endpoint of impacting total mortality, recurrent myocardial infarction, stroke, coronary revascularization, and hospitalization for… -
in Scientific Conferences
REMINDER Trial finds early administration of eplerenone in patients with acute STEMI improves cardiovascular outcomes
SAN FRANCISCO, March 10, 2013 The REMINDER trial, presented on Sunday at the American College of Cardiology 2013 Scientific Sessions, revealed that the addition of eplerenone to standard therapy within 24 hours of symptom onset improves outcomes of patients with acute STEMI without evidence of heart failure. “The benefit of…
Click here to visit Press Release Archive
News MediaJournal of Cardiovascular Nursing PCNA Annual Symposium |
Frequently Requested ResourcesPCNA National Office Staff |
Media ContactAbby Despins Marketing & Public Relations This email address is being protected from spambots. You need JavaScript enabled to view it. O: 608.250.2440 x4 C: 920.606.2115 |
